MedTrace Logo

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

NCT01344837 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 360

Last updated 2024-08-14

No results posted yet for this study

Summary

This research study is studying biomarkers in blood and tissue samples from patients with uterine cancer. Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes the occur in DNA and identify biomarkers related to cancer.

Conditions

  • Endometrial Serous Adenocarcinoma
  • Stage I Uterine Corpus Cancer
  • Stage II Uterine Corpus Cancer
  • Stage III Uterine Corpus Cancer
  • Stage IV Uterine Corpus Cancer

Interventions

OTHER

Diagnostic Laboratory Biomarker Analysis

Correlative studies

OTHER

Immunohistochemistry Staining Method

Correlative studies

OTHER

Medical Chart Review

Correlative studies

GENETIC

Microarray Analysis

Correlative studies

OTHER

Study of Socioeconomic and Demographic Variables

Correlative studies

GENETIC

Western Blotting

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Gynecologic Oncology Group

    lead NETWORK

Principal Investigators

  • Barbara Buttin · Gynecologic Oncology Group

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01344837 on ClinicalTrials.gov